ConductScience.org, home

Paper3024322

Proteolytic enzymes in cancer invasion and metastasis.

Goldfarb RH and 1 other. Semin Thromb Hemost, 1986. Cited by 160 papers, by iCite.

Cite this record

ConductScience Library. Proteolytic enzymes in cancer invasion and metastasis. Papers, record 3024322. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3024322

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Proteolytic enzymes in cancer invasion and metastasis.
PubMed
Journal
Semin Thromb Hemost
PubMed
Year
1986
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
160
iCite
Relative citation ratio, by iCite
4.76
iCite
Revised in PubMed
2022-02-25
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goldfarb RHR H
2Liotta LAL A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neoplasm InvasivenessMajor topic
Neoplasm MetastasisMajor topic
Peptide HydrolasesMajor topic
Cathepsin B
Endopeptidases
Extracellular Matrix
Fibrinolysin
Glycoside Hydrolases
Humans
Microbial Collagenase
Plasminogen Activators
Serine Endopeptidases

Source PubMed

Download CSV of topics

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.

PMIDTitleJournalYearIn PapersSource
38557916Circulating tumor cells clusters and their role in Breast cancer metastasis; a review of literature.Discov Oncol2024https://conductscience.org/library/papers/38557916PubMed
37057291The most likely but largely ignored triggering factor for breast (or all) cancer invasion.J Cancer2023https://conductscience.org/library/papers/37057291PubMed
32216826Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast.Breast Cancer Res2020https://conductscience.org/library/papers/32216826PubMed
28249898Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.Cancer Res2017https://conductscience.org/library/papers/28249898PubMed
27648124Invasive ductal carcinoma with in situ pattern: how to avoid this diagnostic pitfall?Am J Transl Res2016https://conductscience.org/library/papers/27648124PubMed
25057306Metastatic hepatocarcinoma he/de tumor model in rat.J Cancer2014https://conductscience.org/library/papers/25057306PubMed
23532368Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?Int J Med Sci2013https://conductscience.org/library/papers/23532368PubMed
23386907Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.J Cancer2013https://conductscience.org/library/papers/23386907PubMed
23355797Cell budding from normal appearing epithelia: a predictor of colorectal cancer metastasis?Int J Biol Sci2013https://conductscience.org/library/papers/23355797PubMed
21811519Malignant transformation and stromal invasion from normal or hyperplastic tissues: true or false?J Cancer2011https://conductscience.org/library/papers/21811519PubMed
20842227Protein profiling of isolated leukocytes, myofibroblasts, epithelial, Basal, and endothelial cells from normal, hyperplastic, cancerous, and inflammatory human prostate tissues.J Cancer2010https://conductscience.org/library/papers/20842227PubMed
20842226A seemingly most effective target for early detection and intervention of prostate tumor invasion.J Cancer2010https://conductscience.org/library/papers/20842226PubMed
20842222Tumor cell budding from focally disrupted tumor capsules: a common pathway for all breast cancer subtype derived invasion?J Cancer2010https://conductscience.org/library/papers/20842222PubMed
20224734Aberrant leukocyte infiltration: a direct trigger for breast tumor invasion and metastasis.Int J Biol Sci2010https://conductscience.org/library/papers/20224734PubMed
20036817Role of myoepithelial cells in breast tumor progression.Front Biosci (Landmark Ed)2010https://conductscience.org/library/papers/20036817PubMed
19343113Correlated alterations in prostate basal cell layer and basement membrane.Int J Biol Sci2009https://conductscience.org/library/papers/19343113PubMed
18726004Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: a trigger or sign for emergence of more aggressive cell clones?Int J Biol Sci2008https://conductscience.org/library/papers/18726004PubMed
18725981Bad seeds produce bad crops: a single stage-process of prostate tumor invasion.Int J Biol Sci2008https://conductscience.org/library/papers/18725981PubMed
14580259
Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.
Breast Cancer Res2003https://conductscience.org/library/papers/14580259PubMed
12927046A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers.Breast Cancer Res2003https://conductscience.org/library/papers/12927046PubMed

See all 38 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CTSB1508PubTator's text mininghttps://conductscience.org/library/genes/1508

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3024322

GET https://conductscience.org/api/papers/v1/3024322/cited_by?page=2